Wednesday, December 30, 2020

Commentaries, Analysis, And Editorials -- December 30, 2020

 


Health experts worry that the public could balk if offered a shot that's only moderately effective. 

The nation’s first two coronavirus vaccines smashed scientists’ and health officials’ expectations with roughly 95 percent efficacy and no major safety concerns. 

But there aren’t enough doses to go around — and if the next vaccines in the pipeline are merely good instead of great, they could be a hard sell to a skeptical public. 


 Commentaries, Analysis, And Editorials -- December 30, 2020




Why Turkey is upgrading its ties with Israel -- MK Bhadrakumar, Asia Times 

Why America Should Not Be Involved in Yemen -- Fiona Harrigan, National Interest 

Syrian Kurds face betrayal again -- Nikola Mikovic, Asia Times 

The Factories in Xinjiang's Forced Labor Camps -- A. Killing & M. Rajagopalan, Buzz Feed

The Coming Global Backlash against China -- Helen Raleigh, National Review 







No comments: